Welcome to The Zitter Group
The Zitter Group helps life sciences and medical product manufacturers work more effectively with managed care companies. Since 1989, we have worked with and for most of the major pharmaceutical, biotech, and medical device companies – and all of the major managed care organizations. We are considered the premier firm in this segment due to the quality of our service and output. But what really sets us apart from the competition is our:
- The largest payer panel research infrastructure, allowing TZG to field quantitative surveys with 100+ payers
- The largest database of detailed health plan prior authorization policies and formulary information
- The largest syndicated studies focused on payer management of biologic and oncologic therapies, as well as employer and payer practices related to health benefit design
- Innovative advisory programs that are simply more effective than the available alternatives
Our clients work with us because we offer fresh, new options for managed care marketing. We can help you improve the way you:
- Segment your market
- Apply market analytics and position your products
- Conduct advisory boards and educational symposia
- Communicate your product’s value to the managed care audience
- Allocate scarce marketing resources to the best managed care opportunities
Because we have worked with a number of large managed care organizations as well as pharmacy benefits managers (PBMs), we can help you better understand these organizations.
Why Managed Care?
Third party payers – predominantly managed care organizations – account for over three-quarters of prescriptions in the United States. While other audiences, including physicians and patients, remain critical decision-makers, a product’s success (or failure) can be strongly influenced by the commercial payer market. More importantly, in our experience, most life science companies could be doing more – and thus selling more – within the managed care market.
What’s New
- The Winter 2009 edition of The Managed Care Oncology Index, a semi annual primary market research study on the evolution of Oncology management by commercial payers. Learn more.
- TZG is currently fielding the Spring 2009 edition of the Managed Care Biologics and Injectables Index, the largest quantitative analysis of specialty management. Learn more.
- Mark Zitter is interviewed by PharmaVoice on marketing to managed care and the importance of the health plan P&T committee. Click here to listen to the podcast.
- Want to learn more about the pharma-employer relationship? Click here to read our article "Where the Buck Stops" published in the October 2006 issue of Pharmaceutical Executive.